Navigation Links
Effective health messages may yield vaccine compliance among ER workers
Date:6/17/2008

Emergency room workers will be the first line of defense in the event of a disease pandemic and will be forced to deal with the chaos that inevitably comes with treating thousands of sick and dying. In order to protect themselves and allow them to care for the public, these first responders need to be fully prepared by getting available vaccines now.

But how can public health officials convince ER workers to get a vaccine at a time when no threat is imminent, and they are worried about the vaccine's side effects?

In a new study published this month in Biosecurity and Bioterrorism, researchers from the Center for Preparedness Research and Planning and the Department of Public Health at Temple University found that by addressing ER workers' fears and concerns, they could craft persuasive messages to convince ER workers to get vaccinated.

"In the wake of 9/11 and the anthrax attacks, the government tried to implement a program to vaccinate 500,000 healthcare workers against the smallpox virus, which theoretically could be used in a bioterror attack," said lead researcher Sarah Bass, Ph.D., M.P.H., assistant professor of public health at Temple's College of Health Professions. "But it was left to each state to run the program, and each did so differently. As a result, less than 40,000 ER workers nationwide were vaccinated."

Bass noted that study participants were reluctant to get this particular vaccine because it is a live form of the virus and they weren't sure of the effects it would have on their health, if they could spread it to others, or if it would mean missed time from work.

Using a unique method called "perceptual mapping," researchers found that today, with no threat of an attack, ER workers would only be inclined to get vaccinated if they first got a recommendation from a trusted source, such as another hospital or healthcare professional. But when the threat of an outbreak was imminent, participants
'/>"/>

Contact: Renee Cree
renee.cree@temple.edu
215-707-1583
Temple University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Effective treatment for sickle cell underused by doctors
2. Effective Communication of Clinical Studies for Maximum Impact
3. Winning Method - Effective Identification and Development of Clinical Investigators
4. Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies
5. Hand bone mineral density is an effective predictor of mortality in rheumatoid arthritis
6. Whole Milk Cheaper, Effective Contrast Agent for GI Scans
7. Tracking Cancer Drugs Effectiveness
8. ECRI Institutes Alert and Recall Management System Expands Effectiveness with New Content and Filters
9. Exposure Therapy Effective in Preventing Post-Traumatic Stress
10. Study of anti-CD20 therapy effective B cell depletion
11. Whole milk is effective and cost-effective as oral contrast agent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins L...f the H1N1 virus genomic data. It shows that the ...f 3.7 (s.d. 4.5) during the virus,s current outbre...evels this week of 2.0 (s.d. 0.1). The H1N1 infect... Boston (PRWEB) November 27, 2009...
(Date:11/27/2009)..., , SAN FRANCISCO, Nov. 27 /PRNewswire-Firs...) announced that Blair Lambert, CFO/COO, will pres... will be held at the May Fair Hotel in London, Eng.... GMT. ,, To listen to a live broadcast of The ...net, please log on to www.gymboree.com, click on "...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /...merican professional cycling team dedicated to eth...f cycling champions, announced today that it will ...f Transitions Optical as a new sponsor of the team...acturer of adaptive eyewear, offering the most adv...
(Date:11/27/2009)... XenaCare Holdings has an...he Arthritis Foundation, one of the largest nonpro...and public health education. , ...- XenaCare Holdings, Inc. (OTCBB: XCHO), a company...tion of consumer healthcare products, has announce...
(Date:11/27/2009)...Soaring rates to bring unprecedented medical, econ... Nov. 27 (HealthDay News) -- The number of people ...double over the next 25 years, a new study predict...t 44.1 million people with the disease, up from 23... of treating people with diabetes will triple, the...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... Privatizing water supplies is only a pretext for ...precious resources of the people at large, activis...orldwide in the bottled water market, corporations...ontrols one-third of the U.S. market and sells 70 ...
... A revolutionary new imaging technology is expecte...s. Elasticity imaging is an ultrasound technique r... measure the stiffness of tissue, relative to surr...psies turn up positive for cancer. In a re...
... Loading a Super Soaker (a brand of recreational ...ight, worse ejaculating on stuffed animals, how de... are heard these days after a popular 17-year-old .... A week or so later, Mayor Tish Colombi and ...
... New tuberculosis (TB) vaccines in development hav...strains of TB, including multidrug-resistant (MDR)...rald C. Sadoff, president and CEO of the Aeras Glo... solely to creating new TB vaccines, is working to...
... Additional beneficial effects on cardiometabolic ...s in trials of the anti-obesity drug rimonabant ma...e in the June issue of Drug and Therapeutics Bulle...n cardiometabolic risk factors are beyond those ex...
... Tobacco is perhaps the most common addiction all .... Alarmed by the devastating impact of tob...ld Health Organization is calling for stringent re...1 crore, according to WHO estimates. The ...
Other Medicine News:Health News:Multinationals Exploit Groundwater Sources, and People Suffer 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 3Health News:Multinationals Exploit Groundwater Sources, and People Suffer 4Health News:Multinationals Exploit Groundwater Sources, and People Suffer 5Health News:Beer Bashes of Teens Spinning Out of Control in US 2Health News:New TB Vaccines in Could Protect Against All Drug Resistant Strains 2Health News:New TB Vaccines in Could Protect Against All Drug Resistant Strains 3Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2Health News:Tobacco Menace and What can Be Done About It 2Health News:Tobacco Menace and What can Be Done About It 3Health News:Tobacco Menace and What can Be Done About It 4
(Date:11/25/2009)...v. 25 Praxis Electronic Medical Re...n Academy of Family Physicians, (AAFP) Family Prac...urvey for improving medical quality, health mainte...w ARRA Stimulus legislation. Praxis also ranked #1... effect in determining their salary. Finally, Prax...
(Date:11/25/2009)... Pharmasset, Inc. (Nasda...y committed to discovering, developing and commerc...ported financial results for the fiscal year ended...set held $58.4 million in cash, cash equivalents a... and 2009 Highlights ,, RG7128 ,, Phase...
(Date:11/25/2009)... The FDA granted traditional appro...n-nucleoside reverse transcriptase inhibitor (NNRT...ated for use in treatment-experienced adults who a...ns resistant to an NNRTI and other antiretroviral ...n 48-week data from two Phase 3 studies known as D...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Measuring intellectual disability 8977 1Measuring intellectual disability 8977 2M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 1M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 1BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 3BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 4
...IEW, Calif., June 22, 2007 /PRNewswire/ -- MAP,Pha...esent Phase 2,data from its Unit Dose Budesonide (...the World Asthma Meeting at the Lutfi Kirdar,Conve... The oral and poster presentation entitled, "Effic...lation of budesonide for,nebulized delivery in a 6...
... Announces Bioinformatics Partnership with,Illumin...une 21, 2007,-GenoLogics, a leading developer of l... sciences research, today announced that,it has pe...technology partner and participant in IlluminaConn... by Illumina to advance,data integration and analy...
Other Medicine Technology:MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2GenoLogics Announces Bioinformatics Partnership with Illumina 2GenoLogics Announces Bioinformatics Partnership with Illumina 3
Shahinian Lacrimal Cannula
Solo-Care Multipurpose Solution
Graether Collar Button On Handle
Graether Irrigating Collar Button
Medicine Products: